A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Br… (NCT02724371) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction
United States400 participantsStarted 2016-04-01
Plain-language summary
The study will evaluate the long-term safety and effectiveness with the Mentor MemoryGel® Larger Size Ultra High Profile (UHP-L) Breast Implants.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject is female and is at least 18 years old
* A candidate for:
* Primary breast reconstruction in women at least 18 years old with surgically absent breast tissue (two-stage reconstruction \[tissue expanders utilized with or without the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand tissue for study device placement\] to replace breast tissue post-mastectomy)
* Revision surgery in women at least 18 years old with surgically absent breast tissue (previous reconstruction with silicone-filled or saline-filled implants or revision reconstruction requiring expansion surgery prior to surgery for study device implantation, with or without the use of human acellular dermal matrices (ADM), limited to AlloDerm® and FlexHD® PLIABLE, utilized in a prior surgery to expand tissue for study device placement)
* Subject understands and signs the Informed Consent
* Subject agrees to return device to Mentor if device is explanted
* Subject agrees to comply with follow-up procedures, including returning for all follow-up visits
* Physician determines implant volume appropriate for the patient taking into account the subject's BMI and chest width
Exclusion Criteria:
* Subject is pregnant at time of enrollment
* Subject is a current smoker, or has smoked within 3 months prior to enrollment, or plans to resume smoking within 3 months post-enrollment
* Currently has uncontrolled diabetes (at ti…
What they're measuring
1
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Any Reoperation
Timeframe: 10 years
2
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Baker III, IV Capsular Contracture
Timeframe: 10 year
3
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Infection
Timeframe: 10 year
4
10 Year Kaplan-Meier Estimated Cumulative Incidence Rate of Occurrence of Explantation with or without replacement